Cited by 23Cancer-related Molecular PathwaysGenomics and Chromatin DynamicsSignaling Pathways in Disease

An E2F site in the 5′‐promoter region contributes to serum‐dependent up‐regulation of the human proliferating cell nuclear antigen gene

Li, Yuan-Yuan, Wang, Lei, Lu, Chang-De·2003·FEBS Letters

Abstract

The synthesis of proliferating cell nuclear antigen (PCNA) is strictly regulated during the cell cycle. To investigate the contribution of the promoter region to the up‐regulation of human PCNA expression at the onset of S phase, we have examined 17 putative elements with reporter assays in quiescent L‐O2 cells and following serum stimulation. The E2F‐like sequence 5′‐TTCCCCGCAA‐3′ located at −84 to −75 is required for the serum‐induced transactivation. In electrophoretic mobility shift assays, nuclear extracts from asynchronous L‐O2 cells exhibit two binding activities toward the −75 E2F oligonucleotide, and the minor band, whose formation could be interfered with by E2F‐1 antibody, represents an S phase‐specific complex. This is the first demonstration of the E2F site in the human PCNA 5′ promoter as a serum‐responsive element.

Integrity signals

Registry

Crossref · 10.1016/s0014-5793(03)00485-x

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Regulation of PCNA is cell cycle-dependent and is activated by p53.

    “Therefore, the regulation of PCNA is cell cycle-dependent,168 and is activated by p53.169”

    From Census and evaluation of p53 target genes (2017) · cites this paper as [168]

The citation lists haven’t been fetched yet

References 37 · Cited by 23

Authors
Li, Y.-Y., Wang, L., & Lu, C.-D.
Affiliations
Chinese Academy of Sciences (CN)
Corresponding author
Lu, Chang-De
Venue
FEBS Letters
Publisher
Wiley
Published
2003-05-13
Volume
544
Issue
1-3
Pages
112-118
ISSN
  • 0014-5793 (ISSN-L)
  • 1873-3468
OpenAlex
W2085213997
Cited by
23
References
37
Citations by year
2024: 1 · 2021: 3 · 2020: 2 · 2018: 1 · 2017: 2 · 2016: 2 · 2015: 1 · 2013: 1 · 2012: 1
FWCI
0.75
Type
journal article
Language
en
Open access
closed
Locations
  • FEBS Letters (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
Keywords
proliferating cell nuclear antigen, E2F binding sites, promoter, serum response, S phase, E2F1, transcriptional regulation, cell cycle regulation
MeSH terms
Cell Division, Cell Line, Cell Nucleus, Cell Separation, Cloning, Molecular, DNA-Binding Proteins, Flow Cytometry, Humans, Luciferases, Plasmids, Promoter Regions, Genetic, Protein Binding, Time Factors, Transcription Factors, Transfection, Up-Regulation, Resting Phase, Cell Cycle, G1 Phase, Cell Cycle Proteins, Proliferating Cell Nuclear Antigen, E2F Transcription Factors, E2F1 Transcription Factor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review